A Day Up For Virpax Pharmaceuticals Inc.
Wed, Jul 10, 2024 at 07:12 PM
Virpax Pharmaceuticals Inc. (VRPX:NASDAQ) rocketted at $1.7, a gain of 46.6%. On Wed, Jul 10, 2024, VRPX:NASDAQ hit a New 2-Week High of $1.7. The stock got featured on our News Catalysts scanner on Wed, Jul 10, 2024 at 11:53 AM in the 'MISCELLANEOUS' category. From Wed, Jun 26, 2024, the stock recorded 66.67% Up Days and 30.00% Green Days
The stock spiked on Wed, Jul 10, 2024 at $3.39 with a volume of 116M+.
About Virpax Pharmaceuticals Inc. (VRPX:NASDAQ)
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management.
Top 10 Gainers:
- Kazia Therapeutics Limited (KZIA:NASDAQ), 248.02%
- Inspire Veterinary Partners Inc. (IVP:NASDAQ), 110.23%
- Cingulate Inc. (CING:NASDAQ), 74.05%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 73.18%
- Ampco-Pittsburgh Corporation (AP:NYSE), 60.81%
- Longeveron Inc. (LGVN:NASDAQ), 58.54%
- uniQure N.V. (QURE:NASDAQ), 51.72%
- Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 50.83%
- Phoenix New Media Limited (FENG:NYSE), 49.26%
- Virpax Pharmaceuticals Inc. (VRPX:NASDAQ), 46.55%